AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.930
-0.030 (-1.01%)
At close: Feb 27, 2026, 4:00 PM EST
2.963
+0.033 (1.13%)
After-hours: Feb 27, 2026, 6:28 PM EST
AC Immune Market Cap
AC Immune has a market cap or net worth of $289.90 million as of February 27, 2026. Its market cap has increased by 19.99% in one year.
Market Cap
289.90M
Enterprise Value
159.72M
1-Year Change
19.99%
Ranking
Category
Stock Price
$2.93
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $289.90M, a decrease of -66.58%. That is a compound annual growth rate of -10.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 295.60M | -6.69% |
| Dec 31, 2025 | 316.80M | 17.51% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nautilus Biotechnology | 305.66M |
| X4 Pharmaceuticals | 300.78M |
| Cellectis | 294.41M |
| Adlai Nortye | 290.04M |
| Fennec Pharmaceuticals | 289.96M |
| Puma Biotechnology | 287.23M |
| Opus Genetics | 286.89M |
| Minerva Neurosciences | 285.61M |